Avalo Therapeutics (AVTX) Other Gross PP&E Adjustments (2016 - 2025)
Historic Other Gross PP&E Adjustments for Avalo Therapeutics (AVTX) over the last 12 years, with Q3 2025 value amounting to -$402000.0.
- Avalo Therapeutics' Other Gross PP&E Adjustments rose 6470.59% to -$402000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$402000.0, marking a year-over-year increase of 6470.59%. This contributed to the annual value of $722000.0 for FY2024, which is 55.71% up from last year.
- Avalo Therapeutics' Other Gross PP&E Adjustments amounted to -$402000.0 in Q3 2025, which was up 6470.59% from -$487000.0 recorded in Q2 2025.
- In the past 5 years, Avalo Therapeutics' Other Gross PP&E Adjustments registered a high of $722000.0 during Q4 2024, and its lowest value of -$1.9 million during Q1 2022.
- In the last 5 years, Avalo Therapeutics' Other Gross PP&E Adjustments had a median value of -$846000.0 in 2021 and averaged -$789684.2.
- Per our database at Business Quant, Avalo Therapeutics' Other Gross PP&E Adjustments tumbled by 15974.21% in 2022 and then soared by 6470.59% in 2025.
- Quarter analysis of 5 years shows Avalo Therapeutics' Other Gross PP&E Adjustments stood at $587000.0 in 2021, then fell by 0.85% to $582000.0 in 2022, then rose by 23.37% to $718000.0 in 2023, then rose by 0.56% to $722000.0 in 2024, then crashed by 155.68% to -$402000.0 in 2025.
- Its last three reported values are -$402000.0 in Q3 2025, -$487000.0 for Q2 2025, and -$615000.0 during Q1 2025.